FernandoHariThadepalliMDFACP

Internal Medicine • Broomfield, CO

Hospital Medicine/Hospitalist, Preventive Medicine

Assistant Clinical Professor of Medicine

Join to view full profile

Dr. Thadepalli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Thadepalli's full profile

Already have an account?

Office
5023 W 120th Ave
Ste 312
Broomfield, CO 80020
Is this information wrong?

Summary

Dr. Fernando Thadepalli is an internist in Colorado Springs, CO. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 18 years. He speaks primarily English and Spanish. He specializes in hospital medicine/hospitalist and preventive medicine.

Education & Training

University of MinnesotaResidency, Internal Medicine, 1999 - 2002
David Geffen School of Medicine at UCLAClass of 1999

Certifications & Licensure

CA State Medical License 2014 - Present
CO State Medical License 2017 - 2025
UT State Medical License 2015 - 2024
MN State Medical License 2001 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine

Awards, Honors, & Recognition

Top 10 Doctor Vitals.com, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Most Compassionate Doctor American Registry

Publications & Presentations

PubMed

7 citations
Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).
Haragopal Thadepalli, See Kean Chuah, Shugufta Qazi, Fernando Thadepalli, Sastry Gollapudi> ;Chemotherapy. 2001 Jan 1
Difloxacin reverses multidrug-resistance in p388 adr cells via a mechanism independent of p-glycoprotein and without correcting drug transport or subcellular drug dist...
Gupta, S., Thadepalli, F., Gollapudi, S.> ;Int J Oncol. 1995 Sep
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
Thadepalli, H., Reddy, U., Chuah, S. K., Thadepalli, F., Malilay, C., Polzer, R. J., Hanna, N., Esfandiari, A., Brown, P., Gollapudi, S.> ;Antimicrob Agents Chemother. 1997 Mar
Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene.
Gollapudi, S., Thadepalli, F., Kim, C. H., Gupta, S.> ;Oncol Res. 1995
Join now to see all

Other Languages

Spanish